...
机译:米卡芬净在实验性血源性念珠菌脑膜脑炎中的药代动力学和药效学:对新生儿棘手and素治疗的意义。
1 Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda 2 Veterinary Resources Program, Office of Research Services, National Institutes of Health, Bethesda 3 Science Applications International Corporation-Frederick, Inc., Frederick, Maryland 4 Emerging Infectious Diseases Unit, Ordway Research Institute, Albany, New York 5 Astellas Pharma US, Inc., Deerfield, Illinois 6 University of Texas Medical School at Houston, Houston 7 Department of Pediatrics, Duke Clinical Research Institute, Duke University, Durham, North Carolina 8 Infectious Diseases Research Program, Center for Bone Marrow Transplantation and Department of Pediatric Hematology/Oncology, Children's University Hospital, Muenster, Federal Republic of Germany;
机译:米卡芬净在实验性血源性念珠菌脑膜脑炎中的药代动力学和药效学:对棘球菌素治疗新生儿的影响。
机译:阿尼芬净治疗实验性念珠菌眼内炎的药代动力学和药效学:棘球e素在治疗潜在的威胁视力的感染中的作用的见解
机译:氟康唑对隐球菌性脑膜脑炎的药代动力学和药效学:对抗真菌治疗和体外敏感性断点的影响
机译:药代动力学和药效学原理的应用优化牛呼吸道疾病的抗菌治疗:降低抗性发展
机译:个性化移植治疗:专注于造血干细胞和肾脏移植的药物的药代动力学,药效学和药物基因组学。
机译:米卡芬净在实验性血源性念珠菌脑膜脑炎中的药代动力学和药效学
机译:anidulafungin用于实验性念珠菌性眼内炎的药代动力学和药效学:对棘白菌素治疗潜在的视力威胁性感染的效用的见解